profit from every €100 of sales.
€0€100
Coloplast
€67.42+1.32% today
-7.5% since Dec 21, 25
1-year low €49.821-year high €77.26
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
You pay €22.49 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Coloplast sold, what it kept, and what it did with the cash.
Sales went from DKK 19.4 billion in 2021 to DKK 27.0 billion in 2024, with DKK 5.05 billion of profit last year.
SalesProfit
Coloplast handed back more cash to shareholders than it generated last year.
DKK 4.7B
Free cash flow 2024DKK 1.4B
Bought back its own shares–
Paid as dividendsDKK 4.7B
Cash vs. debtDKK 788M vs. DKK 22.6B
Coloplast vs. similar companies
Coloplast grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Coloplast | 22.5× · Fair price | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive |
AI analysis
An AI analyst reads Coloplast's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of DKK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 19,426 | 22,579 | 24,500 | 27,030 | |
| 13,313 | 15,529 | 16,328 | 18,269 | |
| 6,355 | 6,910 | 6,845 | 7,286 | |
| 7,050 | 7,229 | 7,732 | 8,480 | |
| 4,825 | 4,706 | 4,783 | 5,052 | |
| 22.63 | 22.11 | 22.20 | 22.46 | |
| 68.5% | 68.8% | 66.6% | 67.6% | |
| 32.7% | 30.6% | 27.9% | 27.0% | |
| 24.8% | 20.8% | 19.5% | 18.7% |
Balance sheet
| In millions of DKK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 15,841 | 37,446 | 48,159 | 48,073 |
| Cash | 448 | 414 | 911 | 788 |
| Total debt | 2,786 | 18,708 | 19,567 | 22,629 |
| Total liabilities | 7,673 | 29,154 | 30,860 | 30,131 |
| 8,168 | 8,292 | 17,299 | 17,942 | |
| 213 | 213 | 216 | 225 | |
| 40.0% | 16.3% | 12.7% | 12.4% | |
| 59.1% | 56.8% | 27.6% | 28.2% |
Cash flow
| In millions of DKK | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 5,290 | 5,099 | 4,226 | 2,766 | |
| 1,966 | 1,135 | 1,241 | 1,346 | |
| 3,324 | 3,964 | 2,985 | 1,420 | |
| Dividends paid | 3,830 | 4,041 | 4,247 | 4,720 |
| 500 | 619 | 0 | – | |
| – | – | – | – |
Valuation
- 22.5×
- –
- –
- 6.1×
- 4.2×
- 80.0×
- 16.0×
- 1.2%
- 4.4%
- 4.2%
Profitability
- 67.6%
- 27.0%
- 18.7%
- –
- 12.4%
- 13.8%
- –
- –
- –
- –
Growth
- +11.6%
- −0.3%
- –
- –
- +2.8%
Financial health
- 2.6×
- 1.26
- –
- 9.0×
- 1.02
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 20%of 952
Top 12%of 884
Top 42%of 601
Top 46%of 886
Top 50%of 987
4.2%of the share price, paid each year
On $1,000 invested$42a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
93.4% of its profit
Room to growStretchedMore than it earns: 332.4%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
44No pass
Benjamin Graham
42No pass
Philip Fisher
52No pass
Peter Lynch
34No pass
Joel Greenblatt
30No pass
Charlie Munger
46No pass
Terry Smith
38No pass
Questions about Coloplast
Is Coloplast a good stock to buy?
A solid business at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Coloplast AI analysis
What does Coloplast do?
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. It is in Medical Instruments & Supplies, based in Humlebæk, Denmark, with 17,083 employees.
Does Coloplast pay a dividend?
Yes. At today's price the dividend is 4.2% a year, about 93% of its yearly profit. In 2024 it paid out €4.72 billion in dividends.
Is Coloplast stock halal?
Yes. Coloplast passes our halal screen: its business is permitted and its debt is 20% of its market value, under the 30% limit. How we check
Who are Coloplast's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Coloplast's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.